Elutia Inc. Class A Common Stock (ELUT) is a publicly traded Healthcare sector company. As of July 16, 2026, ELUT trades at $0.86 with a market cap of $42.44M and a P/E ratio of 0.75. ELUT moved +3.14% today. Year to date, ELUT is +37.14%; over the trailing twelve months it is -53.20%. Its 52-week range spans $0.50 to $5.12. Analyst consensus is buy with an average price target of $5.00. Rallies surfaces ELUT's financials, insider trades, hedge fund holdings, congressional trades, analyst ratings, and AI-generated research below.
Rallies community data for ELUT shows anonymized retail investor ownership, positioning, sentiment, and portfolio context when enough community data is available.
| Metric | Value |
|---|---|
| Price | $0.86 |
| Market Cap | $42.44M |
| P/E Ratio | 0.75 |
| EPS | $1.29 |
| Dividend Yield | 0.00% |
| 52-Week High | $5.12 |
| 52-Week Low | $0.50 |
| Volume | 66.44K |
| Avg Volume | 0 |
| Revenue (TTM) | $12.29M |
| Net Income | $53.38M |
| Gross Margin | 53.66% |
1 analysts cover ELUT: 0 strong buy, 1 buy, 0 hold, 0 sell, 0 strong sell. Consensus rating is buy. Average price target: $5.00.